FDA Labeling Rule Should Require Statement On Placebo Controls, HRG Says
Executive Summary
FDA should require manufacturers to specify in product labeling whether the drug was approved based on active- or placebo-controlled trials, Public Citizen's Health Research Group maintains in comments on the agency's proposed labeling rule.